The Concept of Biosimilars: From Characterization to Evolution—A Narrative Review

This article highlights the importance of biosimilars, as a cost‐cutting strategy, in the delivery of state‐of‐the‐art health care in developing countries, at a fraction of what a reference biological agent would cost.

Source: The Oncologist - March 9, 2018 Category: Cancer & Oncology Authors: Fadi Farhat, Alfredo Torres, Wungki Park, Gilberto de Lima Lopes, Raja Mudad, Chukwuemeka Ikpeazu, Simon Abi Aad Tags: New Drug Development and Clinical Pharmacology Source Type: research